MYCN impact on high-risk neuroblastoma: from diagnosis and prognosis to targeted treatment
D Bartolucci, L Montemurro, S Raieli, S Lampis… - Cancers, 2022 - mdpi.com
Simple Summary Neuroblastoma is one of the most diffuse and the deadliest cancer in
children. While many advances have been made in the last few decades to improve patients' …
children. While many advances have been made in the last few decades to improve patients' …
Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis
IS Fetahu, W Esser-Skala, R Dnyansagar… - Nature …, 2023 - nature.com
Metastasis is the major cause of cancer-related deaths. Neuroblastoma (NB), a childhood
tumor has been molecularly defined at the primary cancer site, however, the bone marrow …
tumor has been molecularly defined at the primary cancer site, however, the bone marrow …
A molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma
D Corallo, M Dalla Vecchia, D Lazic… - Biochemical …, 2023 - Elsevier
Cell motility is a crucial biological process that plays a critical role in the development of
multicellular organisms and is essential for tissue formation and regeneration. However …
multicellular organisms and is essential for tissue formation and regeneration. However …
[HTML][HTML] Single-cell profiling of peripheral neuroblastic tumors identifies an aggressive transitional state that bridges an adrenergic-mesenchymal trajectory
X Yuan, JA Seneviratne, S Du, Y Xu, Y Chen, Q **… - Cell Reports, 2022 - cell.com
Peripheral neuroblastic tumors (PNTs) represent a spectrum of neural-crest-derived tumors,
including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Malignant cells in …
including neuroblastoma, ganglioneuroblastoma, and ganglioneuroma. Malignant cells in …
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma
Survival in high-risk pediatric neuroblastoma has remained around 50% for the last 20
years, with immunotherapies and targeted therapies having had minimal impact. Here, we …
years, with immunotherapies and targeted therapies having had minimal impact. Here, we …
Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8
Abstract Adult Schwann cells (SCs) possess an inherent plastic potential. This plasticity
allows SCs to acquire repair-specific functions essential for peripheral nerve regeneration …
allows SCs to acquire repair-specific functions essential for peripheral nerve regeneration …
Diagnostic and therapeutic approaches for glioblastoma and neuroblastoma cancers using chlorotoxin nanoparticles
Simple Summary Glioblastoma multiforme (GB) and neuroblastomas (NBs) are nervous
system cancers that are difficult to diagnosis and treat. Chlorotoxin (CTX), is a peptide …
system cancers that are difficult to diagnosis and treat. Chlorotoxin (CTX), is a peptide …
Landscape of bone marrow metastasis in human neuroblastoma unraveled by transcriptomics and deep multiplex imaging
D Lazic, F Kromp, F Rifatbegovic, P Repiscak, M Kirr… - Cancers, 2021 - mdpi.com
Simple Summary Bone marrow metastasis frequently occurs in patients with solid cancers
and most often leads to poor outcome. Yet, the composition of bone marrow metastases …
and most often leads to poor outcome. Yet, the composition of bone marrow metastases …
[HTML][HTML] Three-dimensional in vitro model of bone metastases of neuroblastoma as a tool for pharmacological evaluations
In vitro metastatic models are foreseen to introduce a breakthrough in the field of preclinical
screening of more functional small-molecule pharmaceuticals and biologics. To achieve this …
screening of more functional small-molecule pharmaceuticals and biologics. To achieve this …
MIF/CXCR4 signaling axis contributes to survival, invasion, and drug resistance of metastatic neuroblastoma cells in the bone marrow microenvironment
L Garcia-Gerique, M García, A Garrido-Garcia… - BMC cancer, 2022 - Springer
Background The bone marrow (BM) is the most common site of dissemination in patients
with aggressive, metastatic neuroblastoma (NB). However, the molecular mechanisms …
with aggressive, metastatic neuroblastoma (NB). However, the molecular mechanisms …